221 related articles for article (PubMed ID: 14767719)
1. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
Iłecka J
J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
3. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
5. CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.
Oeckl P; Steinacker P; Lehnert S; Jesse S; Kretzschmar HA; Ludolph AC; Otto M; Ferger B
PLoS One; 2012; 7(3):e32664. PubMed ID: 22396786
[TBL] [Abstract][Full Text] [Related]
6. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
9. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
[TBL] [Abstract][Full Text] [Related]
10. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
11. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H
Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566
[TBL] [Abstract][Full Text] [Related]
13. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
Iłzecka J; Stelmasiak Z; Dobosz B
Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
15. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
16. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
Chełstowska B; Kuźma-Kozakiewicz M
Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.
Iłzecka J
Acta Neurol Scand; 2003 Aug; 108(2):125-9. PubMed ID: 12859290
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
20. Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.
Ikeda M; Sato I; Yuasa T; Miyatake T; Murota S
J Neural Transm Gen Sect; 1995; 100(3):263-7. PubMed ID: 8748672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
